comparemela.com

Latest Breaking News On - Michael leuchten - Page 3 : comparemela.com

NOVO NORDISK : UBS remains a Sell rating

Michael Leuchten from UBS retains his negative opinion on the stock with a Sell rating. The target price continues to be set at DKK 720.

Michael-leuchten
Markets

BAYER AG : UBS reaffirms its Buy rating

In a research note, UBS analyst Michael Leuchten has maintained his recommendation on the stock with a Buy rating. The target price is unchanged at EUR 92.

Michael-leuchten
Markets

GSK plc (NYSE:GSK) Q2 2023 Earnings Call Transcript

Nick Stone: Hello, everyone. Welcome to our Half Year End Q2 2023 conference call webcast investors and analysts.

Japan
United-states
New-york
California
Germany
Delaware
China
Japanese
America
James-gordon
Peter-welford
Simon-baker

BAYER AG : Gets a Buy rating from UBS

Michael Leuchten from UBS retains his positive opinion on the stock with a Buy rating. The target price remains unchanged at EUR 92.

Michael-leuchten
Markets

Novartis AG (NYSE:NVS) Q2 2023 Earnings Call Transcript

Operator: Good morning and good afternoon and welcome to the Novartis Q2 2023 Results Release Conference Call and Live Webcast.

United-kingdom
Italy
Japan
Delaware
United-states
Germany
China
Millburn
Highland
Zaragoza
Baja-california
Mexico

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.